This evidence confirmed that the effect of MCM that we observed in NPC cultures was due to the Nrg-1-modulated microglial secretion and not the original Nrg-1 treatment per se (Supplementary Figures 4i–4t). This evidence concerns the gene NRG1 and nasopharyngeal carcinoma.